GOSS
Price
$0.17
Change
+$0.01 (+6.25%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
84.86M
49 days until earnings call
Intraday BUY SELL Signals
STTK
Price
$5.33
Change
+$0.10 (+1.91%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
514.79M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GOSS vs STTK

GOSS vs STTK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GOSS vs. STTK commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a StrongBuy and STTK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (GOSS: $0.16 vs. STTK: $5.24)
Brand notoriety: GOSS and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 93% vs. STTK: 84%
Market capitalization -- GOSS: $84.86M vs. STTK: $500.46M
GOSS [@Biotechnology] is valued at $84.86M. STTK’s [@Biotechnology] market capitalization is $500.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileSTTK’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • STTK’s FA Score: 0 green, 5 red.
According to our system of comparison, STTK is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 5 TA indicator(s) are bullish while STTK’s TA Score has 5 bullish TA indicator(s).

  • GOSS’s TA Score: 5 bullish, 3 bearish.
  • STTK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both GOSS and STTK are a good buy in the short-term.

Price Growth

GOSS (@Biotechnology) experienced а -1.68% price change this week, while STTK (@Biotechnology) price change was +13.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 11, 2026.

STTK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STTK($515M) has a higher market cap than GOSS($84.9M). STTK YTD gains are higher at: 43.562 vs. GOSS (-94.703). STTK has higher annual earnings (EBITDA): -49.02M vs. GOSS (-168.59M). GOSS has more cash in the bank: 99.2M vs. STTK (90.4M). STTK has less debt than GOSS: STTK (2.89M) vs GOSS (203M). GOSS has higher revenues than STTK: GOSS (55.5M) vs STTK (1M).
GOSSSTTKGOSS / STTK
Capitalization84.9M515M16%
EBITDA-168.59M-49.02M344%
Gain YTD-94.70343.562-217%
P/E RatioN/AN/A-
Revenue55.5M1M5,550%
Total Cash99.2M90.4M110%
Total Debt203M2.89M7,027%
FUNDAMENTALS RATINGS
GOSS: Fundamental Ratings
GOSS
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOSSSTTK
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signal:
Gain/Loss:
STTK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRZKX13.980.01
+0.07%
BlackRock Sust Aware Adg Intl Eq K
SSTFX10.34N/A
N/A
Virtus KAR Capital Growth C
LAFRX22.30N/A
N/A
Lord Abbett Affiliated R3
BINSX15.04N/A
N/A
Baillie Gifford International Alpha I
GQFIX12.94N/A
N/A
GQG Partners Global Quality Value Fd Ins

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with VRTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
+5.86%
VRTX - STTK
36%
Loosely correlated
+3.36%
ADCT - STTK
35%
Loosely correlated
N/A
GOSS - STTK
31%
Poorly correlated
-2.26%
TNYA - STTK
31%
Poorly correlated
-4.19%
SNDX - STTK
30%
Poorly correlated
+1.66%
More